London, UK, Boston, US, April 26, 2012 - IDBS, a global provider of innovative enterprise data management, analytics and modeling solutions, today announced a partnership with the Intellectual Property & Science division of Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals, to transform how researchers access curated biological content and apply it to their research workflow. With this partnership, the companies have integrated their technology through the IDBS ScienceLink scientific content brokerage platform, enabling researchers to access the industry’s most trusted and accurate scientific content from Thomson Reuters IntegritySM, combined with the intuitive delivery methods of the Cortellis Targets API from within E-WorkBook Suite.
ScienceLink, a feature of IDBS’ E-WorkBook enterprise electronic laboratory notebook, allows customers to launch a single query to search and retrieve data from internal systems and from leading licensed external scientific data sources. Thomson Reuters Integrity is a source of reliable, detailed information gathered across multiple disciplines that supports successful drug research and development. With the integration, research teams can now search literature and curated sources via the Cortellis for Informatics Targets API directly within E-WorkBook. Where previously users had to manually collate information, they can now integrate all their available knowledge, accessing data seamlessly and exporting it back to E-WorkBook with a single mouse click.
The combined solution will accelerate biological research in areas such as target identification and validation, experimental pharmacology, toxicology, and biomarker discovery. By bringing together all relevant information ‘just in time’ and at the ‘point of use’, this revolutionary search and delivery of biological content ensures relevant information is available when and where it is needed most, empowering researchers to make the most informed decisions.
“Biology is an important research area for our customers, and we are working to gather and deliver the highest quality and most relevant scientific content across the R&D lifecycle to help organizations speed innovation and deliver actionable insights and results,” said Joseph F. Donahue, Senior Vice President of Global Sales, Thomson Reuters. “We are pleased to be working with IDBS on biology data management to improve the way in which biological content is delivered and used.”
“Partnering with Thomson Reuters, unique in its groundbreaking collection of quality and curated biological content, will streamline advanced biological research for our customers,” said Neil Kipling, Founder and CEO of IDBS. “It is crucial for researchers to have a solid knowledge base of the results of previous studies in order to direct future investigations. Previously, scientists would need to search in various systems and collate data manually. Now they can access insightful data at the right point in their research, presenting considerable savings in time and effort.”
For more information on the Life Sciences Partner Ecosystem, or to become a partner, go to http://cortellis.thomsonreuters.com/partners/.
For further press information, please contact:
idbs@metia.com
+44 (0)20 3100 3647
About Thomson Reuters
Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world’s most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.
About IDBS
IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.
IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments, high-tech materials and consumer products, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and products.
Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan ‘Enabling Technology’ Award in R&D data management for 2010 and Queen’s Award for International Trade 2011.
Further information can be found at www.idbs.com, or follow us on Twitter @IDBSsoftware
